Funds will help launch institute at UF Health for Parkinson’s and other neurodegenerative diseases.
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
MBI director Dr. Todd Golde facilitated a Research!America Town Hall panel including Mary Woolley, retired U.S. Rep. John Edward Porter, Dr. Stephen Sugrue and Dr. David Norton.
Five-year National Institutes of Health Research Education Program, or R25, grant supports residents’ research education activities and academic career development.
Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.
Dr. Golde discussed neuromedicine research on campus — from Alzheimer's disease to age-related memory loss to brain cancer.
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
Catherine Price, Ph.D., an associate professor of clinical health and psychology and anesthesiology, was recently featured in The Gainesville Sun in a feature highlighting the benefits of the new PeCAN program.